Cenntro Inc. (CENN): Nasdaq/NYSE listing notice — Cenntro receives Nasdaq extension until Dec 18, 2023 to meet $1 bid price rule

Cenntro Inc.

180-day extension granted until Dec 18, 2023 to regain compliance with Nasdaq minimum bid price.
Must maintain closing bid price of at least $1.00 for 10 consecutive business days.
Original non-compliance notice from Dec 22, 2022; original deadline was June 20, 2023.
Ordinary shares (CENN) continue trading on Nasdaq Capital Market; no immediate delisting.
No guarantee of compliance; failure by Dec 18 may lead to delisting with appeal rights.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.99

Cenntro Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1), 5810(c)(3)(A)

Exact text from the filing

June 21, 2023, the Company received written notice (the "Notice") from Nasdaq notifying the Company that the Ordinary Shares had not regained compliance with the Minimum Bid Price Requirement. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company is eligible for an additional 180 calendar day period from the date of the receipt of the Notice or until December 18, 2023, to regain compliance with the Minimum Bid Price Requirement. If at any time before December 18, 2023, the bid price of the Company's Ordinary Shares closes at $1.00 per share or more for a minimum of ten consecutive busi

View on SEC.gov

19 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Cenntro Inc. filing history →

Source: SEC EDGAR

accession 0001140361-23-030862

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.